Immunome - Oncology Is Hot

Immunome, an oncology biomedical company, has gained 27.48% since a buy signal on December 22.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.